CY-9d

SI-6449

CY-9d, >98% (HPLC)

CAS No. : [2071682-80-7]

IUPAC Name : 1-(5-(Tert-butyl)isoxazol-3-yl)-3-(2-methyl-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : CY‑9d is a potent MEK/ERK pathway inhibitor, suppressing MEK‑driven ERK phosphorylation and downstream MAPK signaling. In cancer models—including triple‑negative breast cancer (TNBC)—Cy‑9d shows strong anti‑proliferative and pro‑apoptotic activity, making it a useful tool compound for studying MAPK‑dependent tumor biology and evaluating MEK/ERK‑targeted therapeutic strategies.

References : Liao M. et al.: J. Med. Chem., 64(5), 2382-2418, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.